|
1
|
Gandhi J, Chen A, Dagur G, Suh Y, Smith N,
Cali B and Khan SA: Genitourinary syndrome of menopause: An
overview of clinical manifestations, pathophysiology, etiology,
evaluation, and management. Am J Obstet Gynecol. 215:704–711.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Parish SJ, Nappi RE, Krychman ML,
Kellogg-Spadt S, Simon JA, Goldstein JA and Kingsberg SA: Impact of
vulvovaginal health on postmenopausal women: A review of surveys on
symptoms of vulvovaginal atrophy. Int J Womens Health. 5:437–447.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Mac Bride MB, Rhodes DJ and Shuster LT:
Vulvovaginal atrophy. Mayo Clin Proc. 85:87–94. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
North American Menopause Society. The role
of local vaginal estrogen for treatment of vaginal atrophy in
postmenopausal women: 2007 position statement of The North American
Menopause Society. Menopause. 14:357–369. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Benini V, Ruffolo AF, Casiraghi A,
Degliuomini RS, Frigerio M, Braga A, Serati M, Torella M, Candiani
M and Salvatore S: New innovations for the treatment of
vulvovaginal atrophy: An up-to-date review. Medicina (Kaunas).
58(770)2022.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Radnia N, Hosseini S, Vafaei S, Pirdehghan
A and Mehrabadi N: The effect of conjugated estrogens vaginal cream
and a combined vaginal cream of vitamins D and E in the treatment
of genitourinary syndrome. J Fam Med Prim Care.
12(507)2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Rabley A, O'Shea T, Terry R, Byun S and
Louis Moy M: Laser therapy for genitourinary syndrome of menopause.
Curr Urol Rep. 19(83)2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Filippini M, Porcari I, Ruffolo AF,
Casiraghi A, Farinelli M, Uccella S, Franchi M, Candiani M and
Salvatore S: CO2-Laser therapy and genitourinary
syndrome of menopause: A systematic review and meta-analysis. J Sex
Med. 19:452–470. 2022.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Higgins J, Thomas J, Chandler J, Cumpston
M, Li T, Page MJ and Welch VA (eds): Cochrane Handbook for
Systematic Reviews of Interventions. 2nd edition. John Wiley &
Sons, Chichester, UK, 2019.
|
|
10
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. Int J Surg. 88(105906)2021.PubMed/NCBI View
Article : Google Scholar
|
|
11
|
Quick AM, Dockter T, Le-Rademacher J,
Salani R, Hudson C, Hundley A, Terstriep S, Streicher L, Faubion S,
Loprinzi CL, et al: Pilot study of fractional CO2 laser
therapy for genitourinary syndrome of menopause in gynecologic
cancer survivors. Maturitas. 144:37–44. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Page AS, Verbakel JY, Verhaeghe J, Latul
YP, Housmans S and Deprest J: Laser versus sham for genitourinary
syndrome of menopause: A randomised controlled trial. BJOG.
130:312–319. 2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li FG, Maheux-Lacroix S, Deans R,
Nesbitt-Hawes E, Budden A, Nguyen K, Lim CY, Song S, McCormack L,
Lyons SD, et al: Effect of fractional carbon dioxide laser vs. sham
treatment on symptom severity in women with postmenopausal vaginal
symptoms: A randomized clinical trial. JAMA. 326:1381–1389.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mension E, Alonso I, Anglès-Acedo S, Ros
C, Otero J, Villarino Á, Farré R, Saco A, Vega N, Castrejón N, et
al: Effect of fractional carbon dioxide vs. sham laser on sexual
function in survivors of breast cancer receiving aromatase
inhibitors for genitourinary syndrome of menopause: The LIGHT
randomized clinical trial. JAMA Netw Open.
6(E2255697)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cruff J and Khandwala S: A double-blind
randomized sham-controlled trial to evaluate the efficacy of
fractional carbon dioxide laser therapy on genitourinary syndrome
of menopause. J Sex Med. 18:761–769. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Salvatore S, Pitsouni E, Grigoriadis T,
Zacharakis D, Pantaleo G, Candiani M and Athanasiou S:
CO2 laser and the genitourinary syndrome of menopause: A
randomized sham-controlled trial. Climacteric. 24:187–193.
2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ruanphoo P and Bunyavejchevin S: Treatment
for vaginal atrophy using microablative fractional CO2
laser: A randomized double-blinded sham-controlled trial.
Menopause. 27:858–863. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Management of symptomatic vulvovaginal
atrophy: 2013 position statement of The North American Menopause
Society. Menopause. 20:888–902. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Kingsberg SA and Krychman ML: Resistance
and barriers to local estrogen therapy in women with atrophic
vaginitis. J Sex Med. 10:1567–1574. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Salvatore S, Maggiore ULR, Athanasiou S,
Origoni M, Candiani M, Calligaro A and Zerbinati N: Histological
study on the effects of microablative fractional CO2
laser on atrophic vaginal tissue: An ex vivo study. Menopause.
22:845–849. 2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zerbinati N, Serati M, Origoni M, Candiani
M, Iannitti T, Salvatore S, Marotta F and Calligaro A: Microscopic
and ultrastructural modifications of postmenopausal atrophic
vaginal mucosa after fractional carbon dioxide laser treatment.
Lasers Med Sci. 30:429–436. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Perino A, Calligaro A, Forlani F, Tiberio
C, Cucinella G, Svelato A, Saitta S and Calagna G: Vulvo-vaginal
atrophy: A new treatment modality using thermo-ablative fractional
CO2 laser. Maturitas. 80:296–301. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
U.S. Food and Drug Administration:
Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to
safeguard women's health from deceptive health claims and
significant risks related to devices marketed for use in medical
procedures for ‘vaginal rejuvenation’. https://www.fda.gov/news-events/press-announcements/statement-fda-commissioner-scott-gottlieb-md-efforts-safeguard-womens-health-deceptive-health-claims#:~:text=We%20are%20deeply%20concerned%20women,as%20condylomas%20(genital%20warts).
Accessed June 30, 2023.
|
|
24
|
Gorayeb RP, Forjaz MJ, Ferreira AG and
Ferreira JJ: Use of sham interventions in randomized controlled
trials in neurosurgery. J Neurol Surg A Cent Eur Neurosurg.
81:456–462. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
D'Oria O, Giannini A, Buzzaccarini G,
Tinelli A, Corrado G, Frega A, Vizza E and Caserta D: Fractional
CO2 laser for vulvo-vaginal atrophy in gynecologic
cancer patients: A valid therapeutic choice? A systematic review.
Eur J Obstet Gynecol Reprod Biol. 277:84–89. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Khamis Y, Abdelhakim AM, Labib K, Islam
BA, Nassar SA, Motaal AOA, Saleh DM, Abdou H, Abbas AM and Mojahed
EM: Vaginal CO2 laser therapy versus sham for
genitourinary syndrome of menopause management: A systematic review
and meta-analysis of randomized controlled trials. Menopause.
28:1316–1322. 2021.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Seav SM, Dominick SA, Stepanyuk B, Gorman
JR, Chingos DT, Ehren JL, Krychman ML and Su HI: Management of
sexual dysfunction in breast cancer survivors: A systematic review.
Womens Midlife Health. 1(9)2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Vizza R, Capomolla EM, Tosetto L, Corrado
G, Bruno V, Chiofalo B, Di Lisa FS, Filomeno L, Pizzuti L, Krasniqi
E, et al: Sexual dysfunctions in breast cancer patients: Evidence
in context. Sex Med Rev. 11:179–195. 2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gordon C, Gonzales S and Krychman ML:
Rethinking the techno vagina: A case series of patient
complications following vaginal laser treatment for atrophy.
Menopause. 26:423–427. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ahluwalia J, Avram MM and Ortiz AE: Lasers
and energy-based devices marketed for vaginal rejuvenation: A
cross-sectional analysis of the MAUDE database. Lasers Surg Med.
51:671–677. 2019.PubMed/NCBI View Article : Google Scholar
|
